文獻(xiàn)：
1、Journal of Organic Chemistry1961vol. 26p. 2507 - 2510
2、J Contemp Dent Pract. 2016 Dec 1;17(12):1009-1012.Rebamipide to Manage Stomatopyrosis in Oral Submucous Fibrosis.Baptist J1, Shakya S2, Ongole R1.
3、heart failure with preserved ejection fraction：types 1 and 2 ？10.1016/j.jchf.2018.12.017
4、Current status of research on infantile cholestatic liver disease in China: a visualization analysis
Author(s): LIAO Qiong, WAN Chao-Min, ZHU Yu, YANG Xiao-Yan, SHU Min, Department of Pediatrics, West China Second University Hospital, Sichuan University/Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University
5、Diagnosis and differential diagnosis of infantile cholestasis disease
Author(s): Dong Chen, Huang ZhihuaDong Chen: Department of Pediatrics, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China
6、In vitro dissolution and in vivo bioequivalence evaluation of two brands of isosorbide 5-mononitrate sustained release tablets.Kim YH1, Choi KS, Kam SH, Lee KH, Park JS
7、Evaluation of the bioequivalence and pharmacokinetics of two tablet formulations of isosorbide-5-mononitrate after single oral administration in healthy volunteers.
Niopas I1, Daftsios AC, Nikolaidis N.
8、PK/PD analysis of Tebipenem Pivoxil (ME1211),a Novel Oral Carbapenem Antibiotic,in otolaryngological infections,a phase II clinical trial；（新型口服碳青霉烯類抗生素替比培南匹伏酯（ME1211）在耳鼻咽喉感染中的pk/pd分析，一項Ⅱ期臨床試驗(yàn)）
9、PK/PD analysis of Tebipenem Pivoxil (ME1211),a Novel Oral Carbapenem Antibiotic,in otolaryngological infections,a phase II clinical trial；（新型口服碳青霉烯類抗生素替比培南匹伏酯（ME1211）在耳鼻咽喉感染中的pk/pd分析，一項Ⅱ期臨床試驗(yàn)）
10、Trends in the Management of Acute Heart Failure Requiring Intensive Care
Shirakabe A Kobayashi N, kazakh Matsushita M, Shibata Y -, Godah, Shigihara s", AsanKiuchit
11、Patient Selection for Tolvaptan Therapy Among Those With Chronic Kidney Disease and Heart Failure
12、Baumann;?Butler;
[更多]
渝公網(wǎng)安備 50010802001068號
